But doctors at Fox Chase Cancer Center in Philadelphia have presented a novel study suggesting why prostate cancer may recur in some men. To date, no such measurements have been made in prostate carcinomas. The occasional failure of radiation therapy remains an important problem in the treatment of prostate cancer, especially in patients with bulky, locally advanced disease, who comprise approximately 40 to 50 percent of the patient population. Ultimately, the goal is use those strategies to target patients specifically identified to be at risk for poor outcome for radiation treatment based on their oxygen measurements. Such an innovative approach has not been previously explored in patients with prostate cancer.
Radiation therapy remains equally successful in treating prostate cancer as surgery.
Fox Chase Cancer Center is one of 35 National Cancer Institute-designated comprehensive cancer centers in the nation.